Long term outcomes of cluster randomized trial to improve cardiovascular health at population level: The Cardiovascular Health Awareness Program (CHAP)

PLoS ONE

Volumn 13, Issue 9, 2018, Pages

  Dahrouge, Simone ^a,b,c   Kaczorowski, Janusz ^d,e   Dolovich, Lisa ^f,g   Paterson, Michael ^c,f,h   Thabane, Lehana ^f   Tu, Karen ^i,j   Younger, Jaime ^f   Chambers, Larry ^b,c,f,k  

^a UNIVERSITY OF OTTAWA   (Canada)

^b BRUYÈRE RESEARCH INSTITUTE   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j TORONTO WESTERN HOSPITAL   (Canada)

^k York University   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; AGED; ALL CAUSE MORTALITY; ARTICLE; BINOMIAL DISTRIBUTION; CARDIOVASCULAR SYSTEM EXAMINATION; CEREBROVASCULAR ACCIDENT; CLUSTER ANALYSIS; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INTERVENTION STUDY; LONG TERM CARE; MALE; MORBIDITY; OUTCOME ASSESSMENT; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; RANDOMIZED CONTROLLED TRIAL; TOTAL QUALITY MANAGEMENT; AWARENESS; CLINICAL TRIAL; HEART FAILURE; HEART INFARCTION; MORTALITY; MULTICENTER STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AWARENESS; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MYOCARDIAL INFARCTION; STROKE;

EID: 85053149936     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0201802     Document Type: Article

References (53)

1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT, Byers TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, Chen H, Chen JS, Cheng AT- A, Child JC, Cohen A, Colson KE, Cowie BC, Darby S, Darling S, Davis A, Degenhardt L, Dentener F, Des Jarlais DC, Devries K, Dherani M, Ding EL, Dorsey ER, Driscoll T, Edmond K, Ali SE, Engell RE, Erwin PJ, Fahimi S, Falder G, Farzadfar F, Ferrari A, Finucane MM, Flaxman S, Fowkes FG, Freedman G, Freeman MK, Gakidou E, Ghosh S, Giovannucci E, Gmel G, Graham K, Grainger R, Grant B, Gunnell D, Gutierrez HR, Hall W, Hoek HW, Hogan A, Hosgood HD, Hoy D, Hu H, Hubbell BJ, Hutchings SJ, Ibea-nusi SE, Jacklyn GL, Jasrasaria R, Jonas JB, Kan H, Kanis JA, Kassebaum N, Kawakami N, Khang YH, Khatibzadeh S, Khoo JP, Kok C, Laden F, Lalloo R, Lan Q, Lathlean T, Leasher JL, Leigh J, Li Y, Lin JK, Lipshultz SE, London S, Lozano R, Lu Y, Mak J, Malekzadeh R, Mallinger L, Marcenes W, March L, Marks R, Martin R, McGale P, McGrath J, Mehta S, Mensah GA, Merriman TR, Micha R, Michaud C, Mishra V, Hanafiah KM, Mokdad AA, Morawska L, Mozaff arian D, Murphy T, Naghavi M, Neal B, Nelson PK, Nolla JM, Norman R, Olives C, Omer SB, Orchard J, Osborne R, Ostro B, Page A, Pandey KD, Parry CDH, Passmore E, Patra J, Pearce N, Pelizzari PM, Petzold M, Phillips MR, Pope D, Pope CA III, Powles J, Rao M, Razavi H, Rehfuess EA, Rehm JT, Ritz B, Rivara FP, Roberts T, Robinson C, Rodriguez-Portales JA, Romieu I, Room R, Rosenfeld LC, Roy A, Rushton L, Salomon JA, Sampson U, Sanchez-Riera L, Sanman E, Sapkota A, Seedat S, Shi P, Shield K, Shivakoti R, Singh GM, Sleet DA, Smith E, Smith KR, Stapelberg NJC, Steenland K, St+¦ckl H, Stovner LJ, Straif K, Stra-ney L, Thurston GD, Tran JH, Van Dingenen R, van Donkelaar A, Veerman JL, Vijayakumar L, Wein-traub R, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams W, Wilson N, Woolf AD, Yip P, Zielinski JM, Lopez AD, Murray CJL, Ezzati M (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2224–2260. https://doi.org/10.1016/S0140-6736(12)61766-8 PMID: 23245609
2. MacKay J, Mensah GA (2004) The Atlas of Heart Disease and Stroke.
3. Mathers C, Stevens G, Mascarenhas M (2009) Global Health Risks: Mortality and bruden of disease attributable to selected major risks.
4. World Health Organization (2004) Who publishes definitive atlas on global heart disease and stroke epidemic. Indian Journal of Medical Sciences 58: 405–406. PMID: 15902773
5. Vasan RS, Beiser A, Seshadri S (2002) Residual lifetime risk for developing hypertension in middle-aged women and men: The framingham heart study. JAMA 287: 1003–1010. https://doi.org/10.1001/jama.287.8.1003 PMID: 11866648
6. Hemmelgarn BR, Chen G, Walker R, McAlister FA, Quan H, Tu K, Khan N, Campbell N (2008) Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006. The Canadian Journal Of Cardiology 24: 507–512. PMID: 18548150
7. Joffres MR, Campbell NR, Manns B, Tu K (2007) Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada. The Canadian Journal Of Cardiology 23: 437–443. PMID: 17487286
8. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH (1990) Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335: 827–838. 0140-6736(90)90944-Z [pii]. PMID: 1969567
9. Diabetes Prevention Program Research Group (2009) 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374: 1677–1686. https://doi.org/10.1016/S0140-6736(09)61457-4 PMID: 19878986
10. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364: 937–952. https://doi.org/10.1016/ S0140-6736(04)17018-9 PMID: 15364185
11. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV, Williams B, Ford GA (2006) Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. Journal of Hypertension 24: 215–233. https://doi.org/10.1097/01.hjh.0000199800.72563.26 PMID: 16508562
12. Beckett NS, et al. (2008) Treatment of hypertension in patients 80 years of age or older. New England Journal of Medicine 358: 1887–1898. https://doi.org/10.1056/NEJMoa0801369 PMID: 18378519
13. Public Health Agency of Canada (2007) Hypertension facts and figures.
14. Leenen FH, et al. (2008) Results of the Ontario survey on the prevalence and control of hypertension. Canadian Medical Association Journal 178: 1441–1449. https://doi.org/10.1503/cmaj.071340 PMID: 18490640
15. Wilkins K, Campbell NR, Joffres MR, McAlister FA, Nichol M, Quach S, Johansen HL, Tremblay MS (2010) Blood pressure in Canadian adults. Health Rep 21: 37–46.
16. Parati G, Mancia G (2003) White coat effect: semantics, assessment and pathophysiological implications. Journal of Hypertension 21: 481–486. https://doi.org/10.1097/01.hjh.0000052458.40108.adPMID: 12640236
17. Pickering TG (2007) The natural history of hypertension: prehypertension or masked hypertension? J Clin Hypertens (Greenwich), 9: 807–810.
18. Dobbins M, Beyers J (1999) The effectiveness of community-based heart health projects: a systematic overview update. Ontario Public Health Research, Education & Development Program.
19. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: 1747–1757. S0140-6736(06)68770-9 [pii]; https://doi.org/10.1016/S0140-6736(06)68770-9 PMID: 16731270
20. World Health Organization. (2003) Prevention of recurrent heart attacks and strokes in low and middle income populations: evidence based recommendations for policy makers and helath professionals.
21. Manuel DG, Lim J, Tanuseputro P, Anderson GM, Alter DA, Laupacis A, Mustard CA (2006) Revisiting Rose: strategies for reducing coronary heart disease. BMJ 332: 659–662. 332/7542/659 [pii]; https://doi.org/10.1136/bmj.332.7542.659 PMID: 16543339
22. Pennant M, Davenport C, Bayliss S, Greenheld W, Marshall T, Hyde C (2010) Community programs for the prevention of cardiovascular disease: a systematic review. Am J Epidemiol 172: 501–516. kwq171 [pii]; https://doi.org/10.1093/aje/kwq171 PMID: 20667932
23. Pearson TA, et al. (2001) Dissecting the "black box" of community intervention: lessons from community-wide cardiovascular disease prevention programs in the US and Sweden. Scandavian Journal of Public Health Supplement 2001: 69–78.
24. Stone E, Pearson T (1997) Community trials for cardiopulmonary health: directions for public health practice, policy, and research. Annals of Epidemiology S7: S124.
25. Kaczorowski J, Chambers LW, Dolovich L, Paterson JM, Karwalajtys T, Gierman T, Farrell B, McDonough B, Thabane L, Tu K, Zagorski B, Goeree R, Levitt CA, Hogg W, Laryea S, Carter MA, Cross D, Sabaldt RJ (2011) Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ 342: d442. https://doi.org/10.1136/bmj.d442 PMID: 21300712
26. Kaczorowski J, Chambers LW, Karwalajtys T, Dolovich L, Farrell B, McDonough B, Sebaldt R, Levitt C, Hogg W, Thabane L, Tu K, Goeree R, Paterson JM, Shubair M, Gierman T, Sullivan S, Carter M (2008) Cardiovascular Health Awareness Program (CHAP): a community cluster-randomised trial among elderly Canadians. Prev Med 46: 537–544. https://doi.org/10.1016/j.ypmed.2008.02.005 PMID: 18372036
27. Carter M, Karwalajtys T, Chambers L, Kaczorowski J, Dolovich L, Gierman T, Cross D, Laryea S (2009) Implementing a standardized community-based cardiovascular risk assessment program in 20 Ontario communities. Health Promot Int 24: 325–333. dap030 [pii]; https://doi.org/10.1093/heapro/dap030PMID: 19819896
28. Kaczorowski J, Chambers LW, Karwalajtys T, Dolovich L, Farrell B, McDonough B, Sebaldt R, Levitt C, Hogg W, Thabane L, Tu K, Goeree R, Paterson JM, Shubair M, Gierman T, Sullivan S, Carter M (2008) Cardiovascular Health Awareness Program (CHAP): a community cluster-randomised trial among elderly Canadians. Prev Med 46: 537–544. https://doi.org/10.1016/j.ypmed.2008.02.005 PMID: 18372036
29. Kaczorowski J, Chambers LW, Dolovich L, Paterson JM, Karwalajtys T, Gierman T, Farrell B, McDonough B, Thabane L, Tu K, Zagorski B, Goeree R, Levitt CA, Hogg W, Laryea S, Carter MA, Cross D, Sabaldt RJ (2011) Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ 342: d442. https://doi.org/10.1136/bmj.d442 PMID: 21300712
30. Humphries KH, Rankin JM, Carere RG, Buller CE, Kiely FM, Spinelli JJ (2000) Co-morbidity data in outcomes research: are clinical data derived from administrative databases a reliable alternative to chart review? J Clin Epidemiol 53: 343–349. S0895-4356(99)00188-2 [pii]. PMID: 10785564
31. Williams JI YW (1996) A summary of studies on the quality of health care administrative databases in Canada. In: Goel V WJAGB-HPFCNC, editors. Patterns of Health Care in Ontario, The ICES Pratice Atlas. Canadian Medical Association. pp. 339–345.
32. Canadian Institute for Health Information (2011) Data Quality Documentation for External Users: Discharge Abstract Databse, 2010–2011.
33. Ministry of Health and Long Term Care (2006) Ontario Health Planning Data Guide: Release 3.0.
34. Wagner EH (2010) Academia, chronic care, and the future of primary care. J Gen Intern Med 25: Suppl-8.
35. Gupta S (2014) Disparities in multiple risk factors for cardiovascular diseases—Delaware, 2011. Delaware Medical Journal 86: 77–84. PMID: 24933795
36. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K (The burden and costs of chronic diseases in low-income and middle-income countries. The Lancet 370: 1929–1938. https://doi.org/10.1016/ S0140-6736(07)61696-1
37. Reboldi G, Angeli F, de SG, Staessen JA, Verdecchia P, Cardio-Sis I (2014) Tight versus standard blood pressure control in patients with hypertension with and without cardiovascular disease. Hypertension 63: 475–482. https://doi.org/10.1161/HYPERTENSIONAHA.113.02089 PMID: 24343119
38. Brown RE, Riddell MC, Macpherson AK, Canning KL, Kuk JL (2013) The joint association of physical activity, blood-pressure control, and pharmacologic treatment of hypertension for all-cause mortality risk. American Journal of Hypertension 26: 1005–1010. https://doi.org/10.1093/ajh/hpt063 PMID: 23690165
39. Gellert C, Schottker B, Brenner H (2012) Smoking and all-cause mortality in older people: systematic review and meta-analysis. [Review]. Arch Intern Med 172: 837–844. https://doi.org/10.1001/archinternmed.2012.1397 PMID: 22688992
40. Byberg L, Melhus H, Gedeborg R, Sundstrom J, Ahlbom A, Zethelius B, Berglund LG, Wolk A, Michaelsson K (2009) Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. BMJ 338: b688. https://doi.org/10.1136/bmj.b688 PMID: 19264819
41. Dunneram Y, Jeewon R (2015) Healthy Diet and Nutrition Education Program among Women of Reproductive Age: A Necessity of Multilevel Strategies or Community Responsibility. [Review]. Health Promotion Perspectives 5: 116–127. https://doi.org/10.15171/hpp.2015.014 PMID: 26290827
42. Ekpu VU, Brown AK (2015) The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence. [Review]. Tobacco Use Insights 8: 1–35. https://doi.org/10.4137/TUI.S15628PMID: 26242225
43. Desveaux L, Beauchamp M, Goldstein R, Brooks D (2014) Community-based exercise programs as a strategy to optimize function in chronic disease: a systematic review. [Review]. Med Care 52: 216–226. https://doi.org/10.1097/MLR.0000000000000065 PMID: 24374411
44. Vanstone M, Giacomini M, Smith A, Brundisini F, DeJean D, Winsor S (2013) How diet modification challenges are magnified in vulnerable or marginalized people with diabetes and heart disease: a systematic review and qualitative meta-synthesis. [Review]. Ontario Health Technology Assessment Series 13: 1–40.
45. Pennant M, Davenport C, Bayliss S, Greenheld W, Marshall T, Hyde C (2010) Community programs for the prevention of cardiovascular disease: a systematic review. [Review] [56 refs]. Am J Epidemiol 172: 501–516. https://doi.org/10.1093/aje/kwq171 PMID: 20667932
46. Quinones AR, Richardson J, Freeman M, Fu R, O’Neil ME, Motu’apuaka M, Kansagara D (2014) Educational group visits for the management of chronic health conditions: a systematic review. [Review]. Patient Educ Couns 95: 3–29. https://doi.org/10.1016/j.pec.2013.12.021 PMID: 24468199
47. LeFevre ML, U.S.Preventive Services Task Force (2014) Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement.[Summary for patients in Ann Intern Med. 2014 Oct 21; 161(8):I–36; PMID: 25155276]. Ann Intern Med 161: 587–593. http://dx.doi.org/10.7326/M14-1796.
48. Powers MA, Bardsley J, Cypress M, Duker P, Funnell MM, Hess FA, Maryniuk MD, Siminerio L, Vivian E (2015) Diabetes Self-management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Diabetes Care 38: 1372–1382. https://doi.org/10.2337/dc15-0730PMID: 26048904
49. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L (2011) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet 364: 937–952.
50. Yazdanyar A, Newman AB (2009) The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. [Review] [41 refs]. Clin Geriatr Med 25: 563–577. https://doi.org/10.1016/j.cger.2009.07.007 PMID: 19944261
51. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ, American Heart Association Advocacy Coordinating Committee, Stroke C, Council on Cardiovascular Radiology and Intervention, Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiopulmonary, Critical C, Periop-erative and Resuscitation, Council on Cardiovascular Nursing, Council on the Kidney in Cardiovascular Disease, Council on Cardiovascular Surgery and Anesthesia aICoQoCaOR (2011) Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 123: 933–944. https://doi.org/10.1161/CIR.0b013e31820a55f5 PMID: 21262990
52. Goeree R, von Keyserlingk C, Burke N, He J, Kacorowski J, Chambers L, Dolovich L, Paterson JM, Zagorski B (2013) Economic appraisal of a communituy-wide Cardiovascular Health Awareness Program (CHAP). Value Health 16: 39–45. https://doi.org/10.1016/j.jval.2012.09.002 PMID: 23337214
53. Porterfield DS, Hinnant LW, Kane H, Horne J, McAleer K, Roussel A (2012) Linkages between clinical practices and community organizations for prevention: a literature review and environmental scan. [Review]. Am J Prev Med 42: Suppl-71.